Adlyxin vs Mounjaro
Drug comparison
Last updated 2026-05-28 15:46 UTCAdlyxin (lixisenatide) and Mounjaro (tirzepatide) are both injectable medications for type 2 diabetes, but they contain different active ingredients and are made by different companies. Adlyxin is made by Sanofi and contains lixisenatide, while Mounjaro is made by Eli Lilly and contains tirzepatide. Both are given as shots under the skin, but they work in slightly different ways to help control blood sugar.
AI summary of the sources below.
| Adlyxin | Mounjaro | |
|---|---|---|
| Active ingredient | lixisenatide | tirzepatide |
| Manufacturer | sanofi | eli-lilly |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes |
| Label updated | — | 2026-04-22 |